107 related articles for article (PubMed ID: 28947503)
21. Time dependent response of daunorubicin on cytotoxicity, cell cycle and DNA repair in acute lymphoblastic leukaemia.
Al-Aamri HM; Ku H; Irving HR; Tucci J; Meehan-Andrews T; Bradley C
BMC Cancer; 2019 Feb; 19(1):179. PubMed ID: 30813936
[TBL] [Abstract][Full Text] [Related]
22. Evolution of tumor cells during AsiDNA treatment results in energy exhaustion, decrease in responsiveness to signal, and higher sensitivity to the drug.
Girard PM; Berthault N; Kozlac M; Ferreira S; Jdey W; Bhaskara S; Alekseev S; Thomas F; Dutreix M
Evol Appl; 2020 Aug; 13(7):1673-1680. PubMed ID: 32821277
[TBL] [Abstract][Full Text] [Related]
23. Targeted delivery of Dbait by an artificial extracellular vesicle for improved radiotherapy sensitivity of esophageal cancer.
Chen M; Wang Y; Lin J; Galstyan L; Qiao J; Ghazaryan A; Li B; Li H
Am J Cancer Res; 2023; 13(1):105-117. PubMed ID: 36777519
[TBL] [Abstract][Full Text] [Related]
24. The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents.
Lin MZ; Marzec KA; Martin JL; Baxter RC
Oncogene; 2014 Jan; 33(1):85-96. PubMed ID: 23178489
[TBL] [Abstract][Full Text] [Related]
25. DNA-dependent protein kinase: effect on DSB repair, G2/M checkpoint and mode of cell death in NSCLC cell lines.
Sak A; Groneberg M; Stuschke M
Int J Radiat Biol; 2019 Sep; 95(9):1205-1219. PubMed ID: 31287365
[No Abstract] [Full Text] [Related]
26. Inhibition of ATM blocks the etoposide-induced DNA damage response and apoptosis of resting human T cells.
Korwek Z; Sewastianik T; Bielak-Zmijewska A; Mosieniak G; Alster O; Moreno-Villanueva M; Burkle A; Sikora E
DNA Repair (Amst); 2012 Nov; 11(11):864-73. PubMed ID: 23058634
[TBL] [Abstract][Full Text] [Related]
27. Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies.
Koblish H; Li YL; Shin N; Hall L; Wang Q; Wang K; Covington M; Marando C; Bowman K; Boer J; Burke K; Wynn R; Margulis A; Reuther GW; Lambert QT; Dostalik Roman V; Zhang K; Feng H; Xue CB; Diamond S; Hollis G; Yeleswaram S; Yao W; Huber R; Vaddi K; Scherle P
PLoS One; 2018; 13(6):e0199108. PubMed ID: 29927999
[TBL] [Abstract][Full Text] [Related]
28. Mechanism-Based Drug Combinations with the DNA Strand-Breaking Nucleoside Analog CNDAC.
Liu X; Jiang Y; Nowak B; Hargis S; Plunkett W
Mol Cancer Ther; 2016 Oct; 15(10):2302-2313. PubMed ID: 27474148
[TBL] [Abstract][Full Text] [Related]
29. Targeting DNA Repair Pathways in Hematological Malignancies.
Alhmoud JF; Mustafa AG; Malki MI
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036137
[TBL] [Abstract][Full Text] [Related]
30. Pan-PIM kinase inhibition provides a novel therapy for treating hematologic cancers.
Garcia PD; Langowski JL; Wang Y; Chen M; Castillo J; Fanton C; Ison M; Zavorotinskaya T; Dai Y; Lu J; Niu XH; Basham S; Chan J; Yu J; Doyle M; Feucht P; Warne R; Narberes J; Tsang T; Fritsch C; Kauffmann A; Pfister E; Drueckes P; Trappe J; Wilson C; Han W; Lan J; Nishiguchi G; Lindvall M; Bellamacina C; Aycinena JA; Zang R; Holash J; Burger MT
Clin Cancer Res; 2014 Apr; 20(7):1834-45. PubMed ID: 24474669
[TBL] [Abstract][Full Text] [Related]
31. SIRT1 downregulation enhances chemosensitivity and survival of adult T-cell leukemia-lymphoma cells by reducing DNA double-strand repair.
Li L; Ye S; Yang M; Yu W; Fan Z; Zhang H; Hu J; Liang A; Zhang W
Oncol Rep; 2015 Dec; 34(6):2935-42. PubMed ID: 26398583
[TBL] [Abstract][Full Text] [Related]
32. Targeting Sphingosine Kinase Isoforms Effectively Reduces Growth and Survival of Neoplastic Mast Cells With D816V-KIT.
Bandara G; Muñoz-Cano R; Tobío A; Yin Y; Komarow HD; Desai A; Metcalfe DD; Olivera A
Front Immunol; 2018; 9():631. PubMed ID: 29643855
[TBL] [Abstract][Full Text] [Related]
33. Suppression of DNA-dependent protein kinase sensitize cells to radiation without affecting DSB repair.
Gustafsson AS; Abramenkovs A; Stenerlöw B
Mutat Res; 2014 Nov; 769():1-10. PubMed ID: 25771720
[TBL] [Abstract][Full Text] [Related]
34. The Hsp90 inhibitor SNX-7081 is synergistic with fludarabine nucleoside via DNA damage and repair mechanisms in human, p53-negative chronic lymphocytic leukemia.
Kaufman KL; Jenkins Y; Alomari M; Mirzaei M; Best OG; Pascovici D; Mactier S; Mulligan SP; Haynes PA; Christopherson RI
Oncotarget; 2015 Dec; 6(38):40981-97. PubMed ID: 26556860
[TBL] [Abstract][Full Text] [Related]
35. Synergistic anticancer activity of arsenic trioxide with erlotinib is based on inhibition of EGFR-mediated DNA double-strand break repair.
Kryeziu K; Jungwirth U; Hoda MA; Ferk F; Knasmüller S; Karnthaler-Benbakka C; Kowol CR; Berger W; Heffeter P
Mol Cancer Ther; 2013 Jun; 12(6):1073-84. PubMed ID: 23548265
[TBL] [Abstract][Full Text] [Related]
36. Mutational analysis of IkappaBalpha in hematologic malignancies.
Hatta Y; Arima N; Machino T; Itoh T; Hashimoto S; Takeuchi J; Sawada U; Hayakawa S; Yamamoto T; Horie T
Int J Mol Med; 2003 Feb; 11(2):239-42. PubMed ID: 12525885
[TBL] [Abstract][Full Text] [Related]
37. Improving radio-chemotherapy efficacy of prostate cancer by co-deliverying docetaxel and dbait with biodegradable nanoparticles.
Liu N; Ji J; Qiu H; Shao Z; Wen X; Chen A; Yao S; Zhang X; Yao H; Zhang L
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):305-314. PubMed ID: 31858836
[TBL] [Abstract][Full Text] [Related]
38. Pharmacologically Increasing Mdm2 Inhibits DNA Repair and Cooperates with Genotoxic Agents to Kill p53-Inactivated Ovarian Cancer Cells.
Carrillo AM; Hicks M; Khabele D; Eischen CM
Mol Cancer Res; 2015 Aug; 13(8):1197-205. PubMed ID: 25964101
[TBL] [Abstract][Full Text] [Related]
39. Targeting DNA double strand break repair with hyperthermia and DNA-PKcs inhibition to enhance the effect of radiation treatment.
van Oorschot B; Granata G; Di Franco S; Ten Cate R; Rodermond HM; Todaro M; Medema JP; Franken NA
Oncotarget; 2016 Oct; 7(40):65504-65513. PubMed ID: 27602767
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic Implications of p53 Status on Cancer Cell Fate Following Exposure to Ionizing Radiation and the DNA-PK Inhibitor M3814.
Sun Q; Guo Y; Liu X; Czauderna F; Carr MI; Zenke FT; Blaukat A; Vassilev LT
Mol Cancer Res; 2019 Dec; 17(12):2457-2468. PubMed ID: 31551253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
